大洋生物：预计前三季度归母净利润同比增长44.35%-75.56%

Core Viewpoint - The company expects a significant increase in net profit attributable to shareholders for the first three quarters, driven by market demand for its main products, potassium carbonate and veterinary raw materials [1] Financial Performance - The projected net profit for the first three quarters is between 74 million and 90 million yuan, representing a year-on-year growth of 44.35% to 75.56% [1] - The increase in performance is attributed to higher sales volumes and prices compared to the same period last year, along with an improvement in gross profit margin [1]